Leath, C. A., Deng, W., Mell, L. K., Richardson, D. L., Walker, J. L., Holman, L. L., … Monk, B. J. (2023). Incorporation of triapine (T) with cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III randomized trial. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 41).

Leath, Charles A., Wei Deng, Loren K. Mell, Debra L. Richardson, Joan L. Walker, Laura L. Holman, Jayanthi Sivasothy Lea, et al. “Incorporation of triapine (T) with cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III randomized trial.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 41, 2023.

Leath CA, Deng W, Mell LK, Richardson DL, Walker JL, Holman LL, et al. Incorporation of triapine (T) with cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III randomized trial. In: JOURNAL OF CLINICAL ONCOLOGY. 2023.

Leath, Charles A., et al. “Incorporation of triapine (T) with cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III randomized trial.” JOURNAL OF CLINICAL ONCOLOGY, vol. 41, no. 16, 2023.

Leath CA, Deng W, Mell LK, Richardson DL, Walker JL, Holman LL, Lea JS, Amarnath SR, Santos-Reyes LJ, Arend RC, Mayadev J, Jegadeesh N, Disilvestro P, Chon HS, Ghamande SA, Quick AM, Chino JP, Mackay H, Aghajanian C, Monk BJ. Incorporation of triapine (T) with cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III randomized trial. JOURNAL OF CLINICAL ONCOLOGY. 2023.